Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Satellite Biosciences is raising $19,000,000.00 in new funding. Sources indicate as part of senior management Chief Technology Officer, Tom Lowery played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Satellite Biosciences

Satellite Biosciences is leading the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases. Building on 25 years of work in award-winning labs at MIT, Harvard, Penn, and BU, the platform is supported by a strong IP portfolio and is backed by a top tier syndicate.

To learn more about Satellite Biosciences, visit http://www.satellite.bio/

Contact:
Tom Lowery, Chief Technology Officer
617-932-9047
https://www.linkedin.com/in/thomas-lowery-phd/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved